Quantcast

Latest Paclitaxel Stories

2014-11-12 12:30:38

SAN DIEGO, Nov. 12, 2014 /PRNewswire/ -- Sorrento Therapeutics, Inc. (NASDAQ: SRNE; Sorrento), today announced that Dr.

2014-11-05 16:29:43

CYRAMZA now approved both as a single-agent treatment and in combination with chemotherapy INDIANAPOLIS, Nov.

2014-11-04 08:37:22

Study Failed to Meet Secondary Endpoint of Overall Survival THOUSAND OAKS, Calif., Nov.

2014-10-31 08:26:03

- ABRAXANE plus gemcitabine to be PBS listed for Australian patients with metastatic pancreatic cancer from 1 November MELBOURNE, Australia, Oct.

2014-10-30 08:37:34

HARBIN, China, Oct. 30, 2014 /PRNewswire/ -- Yew Bio-Pharm Group, Inc.

2014-10-30 08:35:51

Trial will test the potential synergy between a taxane and TTFields in the treatment of recurrent ovarian cancer ST. HELIER, Jersey, Oct.

2014-10-14 16:28:30

SAN DIEGO, Oct. 14, 2014 /PRNewswire/ -- Sorrento Therapeutics, Inc.

2014-09-05 08:24:05

SAN DIEGO, Sept. 5, 2014 /PRNewswire/ -- Sorrento Therapeutics, Inc.

2014-09-03 16:29:18

In the news release, Oncolytics Biotech® Inc. Announces Completion of Patient Enrollment in U.S.

2014-09-03 08:32:29

CALGARY, Sept. 3, 2014 /PRNewswire/ - Oncolytics Biotech Inc.


Word of the Day
deuteragonist
  • A person in a secondary role, specifically the second most important character (after the protagonist).
The word 'deuteragonist' comes from a Greek word meaning 'an actor of second-class parts'.
Related